Related Experiment Video
Updated: Aug 7, 2025
09:37
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
9.8K
The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency
Marta Santiago1,2, Alessandro Liquori2,3, Esperanza Such1,2,3
1Hematology Department, Hospital La Fe, 46026 Valencia, Spain.
Cancers
|March 11, 2023
Summary
GATA2 deficiency, a hereditary myeloid malignancy syndrome, arises from gene mutations impacting blood cell formation. Allogeneic stem cell transplant is the sole cure, ideally before organ damage occurs.
Area of Science:
- Genetics
- Hematology
- Oncology
Background:
- Hereditary myeloid malignancy syndromes (HMMSs) are rare but clinically significant.
- GATA2 deficiency is a prominent HMMS, caused by mutations in the GATA2 gene.
- GATA2 mutations disrupt hematopoiesis, leading to myelodysplastic syndrome and acute myeloid leukemia.
Purpose of the Study:
- To review the GATA2 gene's structure and function.
- To explore the role of GATA2 mutations in myeloid neoplasms.
- To discuss clinical manifestations and therapeutic strategies for GATA2 deficiency.
Main Methods:
- Literature review of GATA2 gene, mutations, and associated myeloid neoplasms.
- Analysis of clinical presentations and outcomes.
- Overview of current and emerging treatment options, including stem cell transplantation.
Main Results:
- GATA2 mutations lead to impaired hematopoiesis and increased risk of myeloid malignancies.
- Clinical manifestations are variable and can include hematologic and non-hematologic conditions.
- Allogeneic hematopoietic stem cell transplantation is the only curative option.
Conclusions:
- GATA2 deficiency is a critical hereditary condition impacting hematopoiesis.
- Early diagnosis and timely stem cell transplantation are crucial for favorable outcomes.
- Further research into GATA2's role and improved therapies is warranted.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:43Incomplete Dominance
24.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
24.3K
01:27Glucose Transporters
23.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.8K
01:20Inborn Errors of Metabolism
212
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
212
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
132
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
132
01:24Cystic Fibrosis: Management
208
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
208